Northern Trust Corp Coherus Bio Sciences, Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,006,505 shares of CHRS stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,006,505
Previous 896,735 12.24%
Holding current value
$1.08 Million
Previous $932,000 48.93%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.67 - $1.71 $73,545 - $187,706
109,770 Added 12.24%
1,006,505 $1.39 Million
Q3 2024

Nov 13, 2024
SELL
$0.99 - $1.8 $16,840 - $30,619
-17,011 Reduced 1.86%
896,735 $932,000
Q2 2024

Aug 14, 2024
SELL
$1.58 - $2.51 $12,474 - $19,816
-7,895 Reduced 0.86%
913,746 $1.58 Million
Q1 2024

May 14, 2024
SELL
$2.02 - $3.14 $89,641 - $139,343
-44,377 Reduced 4.59%
921,641 $2.2 Million
Q4 2023

Feb 13, 2024
BUY
$1.59 - $3.85 $5,840 - $14,141
3,673 Added 0.38%
966,018 $3.22 Million
Q3 2023

Nov 13, 2023
BUY
$3.74 - $5.45 $621,243 - $905,288
166,108 Added 20.86%
962,345 $3.6 Million
Q2 2023

Aug 11, 2023
BUY
$3.79 - $8.3 $123,436 - $270,322
32,569 Added 4.26%
796,237 $3.4 Million
Q1 2023

May 15, 2023
BUY
$5.89 - $10.52 $74,496 - $133,056
12,648 Added 1.68%
763,668 $5.22 Million
Q4 2022

Feb 13, 2023
SELL
$5.69 - $10.07 $34,731 - $61,467
-6,104 Reduced 0.81%
751,020 $5.95 Million
Q3 2022

Nov 14, 2022
BUY
$7.17 - $13.87 $73,707 - $142,583
10,280 Added 1.38%
757,124 $7.28 Million
Q2 2022

Aug 12, 2022
BUY
$5.86 - $13.23 $244,033 - $550,950
41,644 Added 5.91%
746,844 $5.41 Million
Q1 2022

May 13, 2022
SELL
$10.92 - $16.41 $282,849 - $425,051
-25,902 Reduced 3.54%
705,200 $9.1 Million
Q4 2021

Feb 08, 2022
SELL
$15.81 - $18.99 $160,186 - $192,406
-10,132 Reduced 1.37%
731,102 $11.7 Million
Q3 2021

Nov 15, 2021
SELL
$12.68 - $17.79 $243,139 - $341,123
-19,175 Reduced 2.52%
741,234 $11.9 Million
Q2 2021

Aug 13, 2021
BUY
$12.95 - $15.41 $513,260 - $610,759
39,634 Added 5.5%
760,409 $10.5 Million
Q1 2021

May 12, 2021
SELL
$14.42 - $21.39 $505,392 - $749,676
-35,048 Reduced 4.64%
720,775 $10.5 Million
Q4 2020

Feb 11, 2021
SELL
$16.56 - $18.94 $296,804 - $339,461
-17,923 Reduced 2.32%
755,823 $13.1 Million
Q3 2020

Nov 16, 2020
SELL
$17.41 - $19.89 $619,082 - $707,268
-35,559 Reduced 4.39%
773,746 $14.2 Million
Q2 2020

Aug 14, 2020
BUY
$14.43 - $19.16 $414,299 - $550,102
28,711 Added 3.68%
809,305 $14.5 Million
Q1 2020

May 14, 2020
BUY
$11.67 - $22.53 $22,908 - $44,226
1,963 Added 0.25%
780,594 $12.7 Million
Q4 2019

Feb 14, 2020
SELL
$16.33 - $21.37 $205,676 - $269,155
-12,595 Reduced 1.59%
778,631 $14 Million
Q3 2019

Nov 13, 2019
BUY
$16.3 - $23.37 $1.54 Million - $2.21 Million
94,773 Added 13.61%
791,226 $16 Million
Q2 2019

Aug 13, 2019
BUY
$13.1 - $22.1 $417,025 - $703,531
31,834 Added 4.79%
696,453 $15.4 Million
Q1 2019

May 13, 2019
BUY
$8.38 - $15.5 $117,948 - $218,162
14,075 Added 2.16%
664,619 $9.07 Million
Q4 2018

Feb 12, 2019
SELL
$8.65 - $16.28 $91,897 - $172,958
-10,624 Reduced 1.61%
650,544 $5.89 Million
Q3 2018

Nov 14, 2018
BUY
$14.45 - $20.25 $1.37 Million - $1.91 Million
94,468 Added 16.67%
661,168 $10.9 Million
Q2 2018

Sep 18, 2018
SELL
$10.25 - $17.45 $18,419 - $31,357
-1,797 Reduced 0.32%
566,700 $7.93 Million
Q2 2018

Aug 14, 2018
BUY
$10.25 - $17.45 $934,769 - $1.59 Million
91,197 Added 19.11%
568,497 $7.96 Million
Q1 2018

May 09, 2018
BUY
$9.1 - $13.7 $79,716 - $120,012
8,760 Added 1.87%
477,300 $5.27 Million
Q4 2017

Feb 14, 2018
SELL
$8.35 - $14.4 $1,068 - $1,843
-128 Reduced 0.03%
468,540 $4.12 Million
Q3 2017

Nov 13, 2017
BUY
$11.1 - $14.5 $5.2 Million - $6.8 Million
468,668
468,668 $6.26 Million

Others Institutions Holding CHRS

# of Institutions
130
Shares Held
67.8M
Call Options Held
1.68M
Put Options Held
91.8K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $83.2M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email